Laminin B1 octapeptide P-8
Code | Size | Price |
---|
TAR-TP2389-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-TP2389-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Laminin B1 octapeptide P-8 is a synthetic laminin B1 chain octapeptide with laminin receptor binding ability.
CAS:
130007-44-2
Molecular Weight:
1006.07
Purity:
0.98
SMILES:
C(N[C@H](C(N[C@@H](CC1=CC=C(O)C=C1)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CCCNC(=N)N)C(O)=O)=O)CO)=O)CCC(N)=O)=O)[C@H](CC)C)=O)=O)CCC(N)=O)(=O)[C@H]2N(C([C@H](CC(O)=O)N)=O)CCC2
References
Ali?o SF, Unda FJ, Perez-Yarza G, Ca?avate ML. Are laminin binding sites on tumor cell surface involved in the indomethacin-induced sensitivity to natural cytotoxic cells? Biol Cell. 1989;66(3):255-61. PubMed PMID: 2532553.